Prado Preclinical Research And Development Organization Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 02-01-2025
- Satisfied Charges ₹ 1.46 Cr
as on 02-01-2025
- Revenue 33.63%
(FY 2022)
- Profit 208.75%
(FY 2022)
- Ebitda 94.14%
(FY 2022)
- Net Worth 31.46%
(FY 2022)
- Total Assets -2.83%
(FY 2022)
About Prado Preclinical Research And Development Organization
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹1.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ila Wangikar and Pralhad Wangikar serve as directors at the Company.
- CIN/LLPIN
U73200PN2010PTC137894
- Company No.
137894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prado Preclinical Research And Development Organization Private Limited offer?
Prado Preclinical Research And Development Organization Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Chemical Testing Services, Pharma & Bioanalytical Services, Pharmaceutical Services, Pre Clinical Services, Laboratory & Lab Equipment, Laboratory Consumables, Acute Toxicity Studies, Medical Treatment Services, Dental Treatment Services.
Who are the key members and board of directors at Prado Preclinical Research And Development Organization?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pralhad Wangikar  | Director | 08-Nov-2012 | Current |
| Ila Wangikar | Director | 08-Nov-2012 | Current |
Financial Performance of Prado Preclinical Research And Development Organization.
Prado Preclinical Research And Development Organization Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.63% increase. The company also saw a substantial improvement in profitability, with a 208.75% increase in profit. The company's net worth Soared by an impressive increase of 31.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prado Preclinical Research And Development Organization?
In 2020, Prado Preclinical Research And Development Organization had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Dec 2023 | ₹2.50 M | Open |
Others Creation Date: 27 Nov 2020 | ₹2.00 M | Open |
Others Creation Date: 28 Dec 2020 | ₹1.00 M | Satisfied |
How Many Employees Work at Prado Preclinical Research And Development Organization?
Prado Preclinical Research And Development Organization has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prado Preclinical Research And Development Organization, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prado Preclinical Research And Development Organization's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
